Anchorage police posted the surveillance video on social media in hopes it would lead to the suspect’s identity. So far, no viable tips have come in, spokesperson Christopher Barraza said in an email.
Carlos Moraes, a neurology professor at the University of Miami who wasn’t involved with the study, said research like this opens the door to more advances.“Once someone comes with a breakthrough like this, it will take no time” for other teams to apply the lessons and move forward, he said. “There are barriers, but I predict that they are going to be crossed in the next five to 10 years. Then the whole field will move as a block because we’re pretty much ready.”
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.WASHINGTON (AP) — A man who battled childhood cancer has received the first known, in a study aimed at restoring the fertility of cancer’s youngest survivors.
Jaiwen Hsu was 11 when a leg injury turned out to be bone cancer. Doctors thoughtcould save him but likely leave him infertile. His parents learned researchers at the University of Pittsburgh Medical Center were freezing testicular cells of
in hopes of preserving their future fertility — and signed him up.
Hsu, now 26, is the first to return as an adult and test if reimplanting those cells might work.Provisional data from the Centers for Disease Control and Prevention shows more than 47,000 Americans died from COVID-related causes last year. The virus was the underlying cause for two-thirds of those and it was a contributing factor for the rest. Among them were 231 children whose deaths were deemed COVID-related, 134 of them where the virus was the direct cause -- numbers similar to yearly pediatric deaths from the flu.
The new FDA approach is the culmination of aunder Health Secretary Robert F. Kennedy Jr.
the use of COVID shots and raising questions about the broader availability of vaccines. It was released two days ahead of the first meeting of FDA’s outside vaccine experts under Trump.but with major restrictions on who can get it — and Tuesday’s guidance mirrors those restrictions. The approval came after Trump appointees overruled FDA scientists’ earlier plans to approve the shot without restrictions.